Understanding how fentanyl causes sudden death and finding ways to prevent it
Mechanism and Countermeasure of Fentanyl-Induced Sudden Death
This study is looking into how fentanyl can cause breathing problems that might lead to sudden death, and it's aimed at finding ways to help people who might overdose on opioids by understanding the nerves involved in this process.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lovelace Biomedical Research Institute NIH-funded |
| Lab location | 1 site (Albuquerque, United States) |
| Project ID | NIH-10984969 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind fentanyl-induced sudden death, particularly focusing on how fentanyl affects breathing and leads to apnea. The study aims to identify the specific nerve pathways involved and explore potential countermeasures that could prevent fatal outcomes in cases of overdose. By examining the role of bronchopulmonary C-fibers and their interaction with fentanyl, the research seeks to develop effective treatments for individuals who experience life-threatening respiratory depression. This work is crucial for addressing the public health crisis of opioid overdoses.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults who are at risk of fentanyl overdose, particularly those using illicit fentanyl.
Not a fit: Patients who do not use opioids or are not at risk of opioid overdose may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent sudden death from fentanyl overdoses, potentially saving many lives.
How similar studies have performed: While there have been studies on opioid overdose treatments, the specific mechanisms and countermeasures being investigated in this research are novel and have not been extensively tested.
Where this research is happening
Albuquerque, United States
- Lovelace Biomedical Research Institute — Albuquerque, United States (Active)
Researchers
- Principal investigator: Xu, Fadi — Lovelace Biomedical Research Institute
- Study coordinator: Xu, Fadi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.